Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin.
Rovner
E S
ES
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, USA.
Wein
A J
AJ
D000368:Aged; D001521:Behavior Therapy / Q000379:methods; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods; D003408:Cresols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D010276:Parasympatholytics / Q000627:therapeutic use*; D010665:Phenylpropanolamine; D016032:Randomized Controlled Trials as Topic; D000068737:Tolterodine Tartrate; D014481:United States; D014549:Urinary Incontinence / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy
D001559:Benzhydryl Compounds; D003408:Cresols; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D010276:Parasympatholytics; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate; C005419:oxybutynin